Brief: Cell Biotech receives patent
02/12/2016 01:59
Dec 2 (Reuters) - Cell Biotech Co Ltd 049960.KQ :
* Says it receives patent on Dec. 2, for composition for
preventing or treating irritable bowel syndrome
Source text in Korean: https://goo.gl/tZaLUz
Further company coverage: 049960.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))
Recent news on Cell Biotech
See all newsBrief: Cell Biotech Q2 Operating Profit 1.3 Billion Won, Down 49% From Year Earlier
Brief: Cell Biotech Q1 Operating Profit 1.4 Billion Won, Up 27% From Year Earlier
Brief: Cell Biotech Co Ltd Q4 Operating Profit 2.1 Billion Won, Up 15% From Year Earlier
Brief: Cell Biotech Q2 Operating Profit 2.5 Billion Won, Swings To Profit From Year Earlier
Brief: Cell Biotech Co Q2 Operating Loss 3 Billion Won, Swings To Loss From Year Earlier